Lys19

Site Information
DrVYTLKkFDPMGQQ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 50289929
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	lung cancer ( 1 , 2 , 3 ) , non-small cell lung cancer ( 1 , 2 , 3 ) , non-small cell lung adenocarcinoma ( 1 , 2 , 3 ) , non-small cell large cell lung carcinoma ( 1 )
Relevant cell line - cell type - tissue:	A549 (pulmonary) ( 3 ) , Cal-12T (pulmonary) ( 2 ) , HCC44 (pulmonary) ( 2 ) , HCC78 (pulmonary) ( 1 ) , lung ( 1 , 2 , 3 ) , NCI-H1355 (pulmonary) ( 3 ) , NCI-H1437 (pulmonary) ( 2 ) , NCI-H1666 (pulmonary) ( 2 ) , NCI-H1781 (pulmonary) ( 1 ) , NCI-H1792 (pulmonary) ( 3 ) , NCI-H2228 (pulmonary) ( 1 ) , NCI-H23 (pulmonary) ( 3 ) , NCI-H2405 (pulmonary) ( 2 ) , NCI-H3122 (pulmonary) ( 1 ) , NCI-H441 (pulmonary) ( 3 ) , NCI-H661 (pulmonary) ( 1 )

References
1	Rikova K (2013) CST Curation Set: 20219; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
2	Rikova K (2013) CST Curation Set: 20220; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
3	Rikova K (2013) CST Curation Set: 20215; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info